Article

Chemotherapeutic Agents Increase PD-L1 Expression in A549 Lung Cancer Cell Line

2021-06-17

Abstract excerpt

<title>Abstract</title> <p>Introduction: With the highest mortality rate, lung cancer is one of the most prevalent malignancies worldwide. Increasing PD-L1 expression is one of the mechanisms of ineffective anti-tumor response and immune evasion, which causes poor prognosis and survival rate. Chemotherapy has its own limitations such as drug resistance and the escape of cancer cells from the immune system. The c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8635f591-98b4-521b-b283-86ec0db37e7b
DOI: 10.21203/rs.3.rs-573138/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Chemotherapeutic Agents Increase PD-L1 Expression in A549 Lung Cancer Cell LineDOI 10.21203/rs.3.rs-573138/v1Read

The Effects of Chemotherapeutic Drugs on PD-L1 Gene Expression in Breast Cancer Cell LinesSemantic proximity Read

[Research Progress of Anti-PD-1/PD-L1 Therapy for Non-small Cell Lung Cancer with EGFR Mutation].Semantic proximity Read

Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-AnalysisSemantic proximity Read

Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World.Semantic proximity Read

Who Will Benefit Most From PD-L1 Detection and Immunotherapy in Non-small Cell Lung Cancer?Semantic proximity Read

Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments.Semantic proximity Read

Influence of PD-L1 expression on the efficacy of EGFR-TKIs in EGFR-mutant non-small cell lung cancer.Semantic proximity Read

[Study Progression on Non-small Cell Lung Cancer with EGFR Mutation Treated by Immune Checkpoint Inhibitors].Semantic proximity Read

PD-1/PD-L1 Axis in Lung Cancer.Semantic proximity Read

[A Real-world Study on the Expression Characteristics of PD-L1 in Patients with Advanced EGFR Positive NSCLC and Its Relationship with the Therapeutic Efficacy of EGFR-TKIs].Semantic proximity Read

Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors.Semantic proximity Read

In-Depth Genomic Characterization of Programmed Cell Death Ligand 1 (PD-L1) Expression in Chinese Lung Adenocarcinoma PatientsSemantic proximity Read